Autologous Multipotent Mesenchymal Stromal Cells in the Treatment of Amyotrophic Lateral Sclerosis
Condition: Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention: Biological: Suspension of human autologous MSC 3P in 1.5 ml Sponsors: Bioinova, s.r.o.; Department of Neurology, University Hospital Motol, Prague, Czech Republic Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials